Straits Times Index
3,314.14 +8.12 (+0.25%) S&P 500
5,462.71 -1.91 (-0.03%) Dow
39,216.60 +66.27 (+0.17%) Nasdaq
17,657.68 -31.68 (-0.18%) Bitcoin USD
61,427.45 -2,861.10 (-4.45%) CMC Crypto 200
1,258.51 -51.21 (-3.91%)
SENS Jan 2026 1.000 call
- Business Wire
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
GERMANTOWN, Md., June 13, 2024--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to host a business update and analyst event during the American Diabetes Association’s 84th Scientific Sessions in Orlando, FL.
- Business Wire
Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
GERMANTOWN, Md., May 29, 2024--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Sidoti Small Cap Conference, being held in virtually.
- Zacks
Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales
Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.
